Tempus Wealth Planning LLC Sells 4,700 Shares of Nano-X Imaging Ltd. (NASDAQ:NNOX)

Tempus Wealth Planning LLC lessened its holdings in Nano-X Imaging Ltd. (NASDAQ:NNOX) by 3.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 116,437 shares of the company’s stock after selling 4,700 shares during the quarter. Tempus Wealth Planning LLC owned 0.20% of Nano-X Imaging worth $838,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in NNOX. Farther Finance Advisors LLC acquired a new position in Nano-X Imaging in the third quarter worth about $25,000. Verition Fund Management LLC bought a new stake in shares of Nano-X Imaging in the 3rd quarter valued at approximately $88,000. Gainplan LLC acquired a new position in shares of Nano-X Imaging in the 4th quarter worth approximately $92,000. Creative Planning bought a new position in shares of Nano-X Imaging during the 3rd quarter worth approximately $107,000. Finally, SG Americas Securities LLC acquired a new stake in Nano-X Imaging in the 3rd quarter valued at $124,000. Institutional investors and hedge funds own 21.49% of the company’s stock.

Nano-X Imaging Price Performance

Shares of NNOX opened at $7.08 on Tuesday. Nano-X Imaging Ltd. has a one year low of $5.26 and a one year high of $14.28. The business’s 50 day simple moving average is $7.58 and its 200-day simple moving average is $6.90.

Nano-X Imaging (NASDAQ:NNOX) last announced its earnings results on Thursday, November 21st. The company reported ($0.23) EPS for the quarter. Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%. During the same period in the prior year, the firm posted ($0.37) EPS. On average, sell-side analysts predict that Nano-X Imaging Ltd. will post -0.92 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have issued reports on NNOX. D. Boral Capital initiated coverage on Nano-X Imaging in a research note on Monday, January 6th. They set a “buy” rating and a $23.00 price objective for the company. Cantor Fitzgerald increased their target price on shares of Nano-X Imaging from $11.00 to $12.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.